Canadian Online Pharmacy

CDER New August 20, 2013

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

August 19, 2013


New and Generic Drug Approvals

August 16, 2013

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Besivance besifloxacin hydrochloride Suspension/Drops; Ophthalmic Bausch and Lomb Manufacturing Change or Addition
Diabeta glyburide Tablet; Oral Sanofi Aventis Us Manufacturing Change or Addition
Firmagon degarelix acetate Powder; Subcutaneous Ferring Labeling Revision
Flagyl metronidazole Tablet; Oral Gd Searle Llc Labeling Revision
Flagyl metronidazole Capsule; Oral Gd Searle Llc Labeling Revision
Flagyl Er metronidazole Tablet, Extended Release; Oral Gd Searle Llc Labeling Revision
Flagyl I.V. metronidazole hydrochloride Injectable; Injection Pfizer Labeling Revision
Flagyl I.V. Rtu In Plastic Container metronidazole Injectable; Injection Pfizer Labeling Revision
Gliadel carmustine Implant; Intracranial Arbor Pharms Llc Labeling Revision
Omeprazole omeprazole Tablet, Delayed Release; Oral Dexcel Pharma Labeling Revision
Oxytrol For Women oxybutynin Film, Extended Release; Transdermal Msd Consumer Manufacturing Change or Addition
Progesterone progesterone Capsule; Oral Banner Pharmacaps Approval
Prograf tacrolimus Injectable; Injection Astellas Manufacturing Change or Addition
Trokendi Xr topiramate Capsule, Extended Release; Oral Supernus Pharmaceuticals Inc. Approval
Vogelxo testosterone Gel; Topical Upsher Smith Labs Tentative Approval
Zoledronic Acid zoledronic acid Injectable; Iv (Infusion) Pharmaceutics Approval

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery